» Articles » PMID: 12697736

A Humanized Model of Experimental Autoimmune Uveitis in HLA Class II Transgenic Mice

Abstract

Experimental autoimmune uveitis (EAU) is a disease of the neural retina induced by immunization with retinal antigens, such as interphotoreceptor retinoid-binding protein (IRBP) and arrestin (retinal soluble antigen, S-Ag). EAU serves as a model for human autoimmune uveitic diseases associated with major histocompatibility complex (HLA) genes, in which patients exhibit immunological responses to retinal antigens. Here we report the development of a humanized EAU model in HLA transgenic (TG) mice. HLA-DR3, -DR4, -DQ6, and -DQ8 TG mice were susceptible to IRBP-induced EAU. Importantly, HLA-DR3 TG mice developed severe EAU with S-Ag, to which wild-type mice are highly resistant. Lymphocyte proliferation was blocked by anti-HLA antibodies, confirming that antigen is functionally presented by the human MHC molecules. Disease could be transferred by immune cells with a Th1-like cytokine profile. Antigen-specific T cell repertoire, as manifested by responses to overlapping peptides derived from S-Ag or IRBP, differed from that of wild-type mice. Interestingly, DR3 TG mice, but not wild-type mice, recognized an immunodominant S-Ag epitope between residues 291 and 310 that overlaps with a region of S-Ag recognized by uveitis patients. Thus, EAU in HLA TG mice offers a new model of uveitis that should represent human disease more faithfully than currently existing models.

Citing Articles

Dietary caloric restriction protects experimental autoimmune uveitis by regulating Teff/Treg balance.

Li Z, Duan R, Jiang Q, Liu J, Chen J, Jiang L iScience. 2024; 27(12):111279.

PMID: 39628557 PMC: 11612795. DOI: 10.1016/j.isci.2024.111279.


Pathogenesis and current therapies for non-infectious uveitis.

Wu X, Tao M, Zhu L, Zhang T, Zhang M Clin Exp Med. 2022; 23(4):1089-1106.

PMID: 36422739 PMC: 10390404. DOI: 10.1007/s10238-022-00954-6.


Multimodal evaluation of an interphotoreceptor retinoid-binding protein-induced mouse model of experimental autoimmune uveitis.

Yang J, Yun K, Jeon J, Yang H, Kim B, Jeong S Exp Mol Med. 2022; 54(3):252-262.

PMID: 35264718 PMC: 8979956. DOI: 10.1038/s12276-022-00733-z.


Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis.

John S, Bell O, Wilson L, Copland D, Pepple K J Vis Exp. 2022; (178).

PMID: 34978282 PMC: 8988856. DOI: 10.3791/62925.


Therapeutic Effect of IL-38 on Experimental Autoimmune Uveitis: Reprogrammed Immune Cell Landscape and Reduced Th17 Cell Pathogenicity.

Li H, Zhu L, Wang R, Xie L, Chen Y, Duan R Invest Ophthalmol Vis Sci. 2021; 62(15):31.

PMID: 34967854 PMC: 8727319. DOI: 10.1167/iovs.62.15.31.


References
1.
Egwuagu C, Charukamnoetkanok P, Gery I . Thymic expression of autoantigens correlates with resistance to autoimmune disease. J Immunol. 1997; 159(7):3109-12. View

2.
Cosgrove D, Gray D, Dierich A, Kaufman J, Lemeur M, Benoist C . Mice lacking MHC class II molecules. Cell. 1991; 66(5):1051-66. DOI: 10.1016/0092-8674(91)90448-8. View

3.
Puig J, ARENDT A, Tomson F, Abdulaeva G, Miller R, HARGRAVE P . Synthetic phosphopeptide from rhodopsin sequence induces retinal arrestin binding to photoactivated unphosphorylated rhodopsin. FEBS Lett. 1995; 362(2):185-8. DOI: 10.1016/0014-5793(95)00225-x. View

4.
Cuccia Belvedere M, Martinetti M, De Paoli F, Mazzacane D, Redaelli C, Tafi A . Genetic heterogeneity in uveitis. Dis Markers. 1986; 4(3):243-6. View

5.
Olerup O, Aldener A, Fogdell A . HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens. 1993; 41(3):119-34. DOI: 10.1111/j.1399-0039.1993.tb01991.x. View